(1GALD.MI) Stock Price, Forecast & Analysis
Europe - BIT:1GALD -
1GALD.MI Key Statistics, Chart & Performance
The current stock price of 1GALD.MI is 162 null.
1GALD.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| SAN.PA | SANOFI | 11.24 | 208.13B | ||
| SNW.DE | SANOFI | 11.24 | 208.11B | ||
| MRK.DE | MERCK KGAA | 12.86 | 47.59B | ||
| UCB.BR | UCB SA | 35.31 | 44.10B | ||
| 1BAYN.MI | BAYER AG-REG | 5.28 | 26.00B | ||
| BAYN.DE | BAYER AG-REG | 5.2 | 25.60B | ||
| REC.MI | RECORDATI INDUSTRIA CHIMICA | 25.24 | 10.40B | ||
| IPN.PA | IPSEN | 12.05 | 10.38B | ||
| TUB.BR | FINANCIERE DE TUBIZE | 97.84 | 9.06B | ||
| VIRP.PA | VIRBAC SA | 19.9 | 2.89B | ||
| DMP.DE | DERMAPHARM HOLDING SE | 16.58 | 1.78B | ||
| MEDCL.PA | MEDINCELL SA | N/A | 1.05B |
Related stock screener links
About 1GALD.MI
Company Profile
Galderma Group AG engages in the provision of science-based premium dermatology solutions. The company is headquartered in Zug, Zug. The company went IPO on 2024-03-22. The Company, throw its subsidiaries, operates a portfolio of carious self-care brands focusing primarily on dermatological solutions, through its subsidiaries. production within the portfolio include neuromodulators, fillers. and biostimulators. these products are designed to relax winkles via injection, fill wrinkles in a specific location via injection and stimulate the body's cells to function optimally. The production process, for the various products primarily takes place in house, form research and development to manufacturing. In addition, including education, scientific engagements, and other services are offered.
Company Info
Zaehlerweg 10
Zug ZUG CH
Employees: 6545
Phone: 41584558592
/ 1GALD.MI FAQ
What does do?
Galderma Group AG engages in the provision of science-based premium dermatology solutions. The company is headquartered in Zug, Zug. The company went IPO on 2024-03-22. The Company, throw its subsidiaries, operates a portfolio of carious self-care brands focusing primarily on dermatological solutions, through its subsidiaries. production within the portfolio include neuromodulators, fillers. and biostimulators. these products are designed to relax winkles via injection, fill wrinkles in a specific location via injection and stimulate the body's cells to function optimally. The production process, for the various products primarily takes place in house, form research and development to manufacturing. In addition, including education, scientific engagements, and other services are offered.
What is the stock price of today?
The current stock price of 1GALD.MI is 162 null.
What is the dividend status of ?
(1GALD.MI) has a dividend yield of 0.04%. The yearly dividend amount is currently 0.
What is the ChartMill technical and fundamental rating of 1GALD stock?
1GALD.MI has a ChartMill Technical rating of 1 out of 10.You can find more details on the Technical Analysis and Fundamental Analysis tabs.
Who owns ?
You can find the ownership structure of (1GALD.MI) on the Ownership tab.
1GALD.MI Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to 1GALD.MI.
1GALD.MI Financial Highlights
Over the last trailing twelve months 1GALD.MI reported a non-GAAP Earnings per Share(EPS) of 1.37. The EPS increased by 2757.69% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.2% | ||
| ROA | 1.83% | ||
| ROE | 2.97% | ||
| Debt/Equity | 0.35 |
1GALD.MI Forecast & Estimates
19 analysts have analysed 1GALD.MI and the average price target is 169.88 null. This implies a price increase of 4.86% is expected in the next year compared to the current price of 162.
For the next year, analysts expect an EPS growth of 66.53% and a revenue growth 17.07% for 1GALD.MI